A multicenter randomized placebo-controlled trial of intravenous thyroxine for heart-eligible brain-dead organ donors

Keyphrases

• Brain Death 25%
• Brain-dead Donor 100%
• Cardiac Ejection Fraction 25%
• Cardiac Performance 25%
• Cardiac Stunning 25%
• Donor Management 50%
• Echocardiography 25%
• Enhanced Stability 25%
• Hemodynamic Instability 50%
• Hemodynamic Stability 25%
• Inferior Function 25%
• Major Contributor 25%
• Multiple Organs 25%
• Organ Donor 25%
• Organ Donor Management 25%
• Organ Procurement Organization 50%
• Pituitary Hormones 25%
• Placebo 25%
• Randomized Controlled Study 25%
• Randomized Placebo-controlled Trial 100%
• Thyroid Hormone Replacement 25%
• Thyroid Hormones 50%
• Thyroxine 100%
• Thyroxine Treatment 50%
• Transplantation 25%
• Trial Registration 25%
• Vasopressor Support 25%
• Vasopressors 25%

Medicine and Dentistry

• Brain Death 16%
• Donor Management 50%
• Echocardiography 16%
• Ejection Fraction 16%
• Heart Performance 16%
• Hemodynamic 66%
• Hormone Therapy 16%
• Hypertensive Factor 33%
• Hypophysis Hormone 16%
• Organ Donor 100%
• Organ Transplantation 33%
• Placebo 100%
• Table Salt 16%
• Thyroid Hormone 33%
• Thyrotropin 16%
• Thyroxine 100%

Immunology and Microbiology

• Heart Ejection Fraction 25%
• Heart Performance 25%
• Hemodynamic 100%
• Organ Procurement Organization 50%
• Pituitary Hormone 25%
• Thyroid 25%
• Thyroid Hormone 50%